The Turkish Competition Authority clears with remedy a merger in the pharmaceuticals sector subject to remedies, including transfer of licences to third parties (Glaxo-SmithKline)

The operation Prior to the transaction Glaxo was a public company which was engaged in research, development, production and marketing in the pharmaceuticals sector. Glaxo had a Turkish subsidiary named Glaxo Wellcome Ilaclarý San. A.S. (“Glaxo Turkey”) through which Glaxo carried out its activities in Turkey. SmithKline was also a public company which was engaged in research, development, production, marketing of primarily medicines, vaccines, OTC medicines and other pharmaceuticals. SmithKline carried out its activities in Turkey through its Turkish Subsidiary,

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Zümrüt Esin, The Turkish Competition Authority clears with remedy a merger in the pharmaceuticals sector subject to remedies, including transfer of licences to third parties (Glaxo-SmithKline), 3 August 2000, e-Competitions August 2000, Art. N° 20895

Visites 1732

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues